A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects
Phase 2
Terminated
- Conditions
- Acute Kidney Injury
- Interventions
- Biological: Vehicle OnlyBiological: AC607
- First Posted Date
- 2012-05-21
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- AlloCure Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT01602328
- Locations
- ๐จ๐ฆ
Toronto General Hospital, Toronto, Ontario, Canada
๐จ๐ฆSt. Michael's Hospital, Toronto, Ontario, Canada
๐บ๐ธNorthwestern University, Chicago, Illinois, United States
Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery
Phase 1
Completed
- Conditions
- Kidney Tubular Necrosis, Acute
- Interventions
- Biological: Multipotent Stromal CellsBiological: Administration of MSC
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- AlloCure Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00733876
- Locations
- ๐บ๐ธ
Intermountain Medical Center, Murray, Utah, United States
๐บ๐ธSt Mark's Hospital, Salt Lake City, Utah, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath